Company Profiles

driven by the PitchBook Platform

Antiva Biosciences

Description

Developer of therapeutics and small molecule antivirals intended to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's medicinal chemistry platform focuses on the development and commercialization of direct acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses, enabling patients to recover HPV-related diseases and other viruses.

2012

Founded

PRIVATE

Status

1-10

Employees

Series C

Latest Deal Type

$22M

Latest Deal Amount

$42M

Total Amount Raised

Description

Developer of therapeutics and small molecule antivirals intended to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's medicinal chemistry platform focuses on the development and commercialization of direct acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses, enabling patients to recover HPV-related diseases and other viruses.

Website:

www.antivabio.com

Formerly Known As

Hera Therapeutics

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

6000 Shoreline Court Suite 203 South San Francisco, CA 94080United States +1 (650) 822-1400
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Antiva Biosciences's full profile, request a free trial.

    Antiva Biosciences Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Antiva Biosciences Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Antiva Biosciences Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alexandria Venture InvestmentsCorporate Venture CapitalMinority000 0000000 0000
    Brace Pharma CapitalCorporate Venture CapitalMinority000 0000000 0000
    Canaan PartnersVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    JLABSAccelerator/Incubator000 0000000 0000
    Alexandria Venture Investments Corporate Venture Capital
    Brace Pharma Capital Corporate Venture Capital
    Canaan Partners Venture Capital
    Individual Investor Angel (individual)
    JLABS Accelerator/Incubator

    Antiva Biosciences Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Gail MaderisPresident, Chief Executive Officer & Board Member
    Karl Hostetler MDFounder & Co-inventor
    Keith Bley Ph.DSenior Vice President, Development
    Raju Gadiraju Ph.DVice President of Pharmaceutical Development and Manufacturing
    Oranee Daniels MDChief Medical Officer
    Gail Maderis President, Chief Executive Officer & Board Member
    Karl Hostetler MD Founder & Co-inventor
    Keith Bley Ph.D Senior Vice President, Development
    Raju Gadiraju Ph.D Vice President of Pharmaceutical Development and Manufacturing
    Oranee Daniels MD Chief Medical Officer

    Antiva Biosciences Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    David Kabakoff Ph.DSofinnova VenturesExecutive Partner, Private Equity000 0000
    Gail MaderisAntiva BiosciencesPresident, Chief Executive Officer & Board Member000 0000
    Michael CannonSelfBoard Member000 0000
    Steven JamesSelfExecutive Chairman000 0000
    Vinzenz PloererBrace Pharma CapitalPresident & Chief Executive Officer000 0000
    David Kabakoff Ph.D Executive Partner, Private Equity Sofinnova Ventures
    Gail Maderis President, Chief Executive Officer & Board Member Antiva Biosciences
    Michael Cannon Board Member Self
    Steven James Executive Chairman Self
    Vinzenz Ploerer President & Chief Executive Officer Brace Pharma Capital
    Request full access to PitchBook